Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical characteristics and outcome of early-stage diffuse large B cell lymphoma of female genital track: A retrospective study of the Hellenic cooperative lymphoma group.
Verrou E, Papageorgiou SG, Bouzani M, Sevastoudi A, Triantafyllou T, Daiou A, Dalampira D, Arapaki M, Giatra C, Banti A, Kyriakidis G, Stoumpos D, Karampatzakis N, Papadopoulou T, Kotsopoulou M, Pouli A, Mandala E, Pappa V, Spanoudakis E, Katodritou E, Vassilakopoulos TP. Verrou E, et al. Among authors: arapaki m. Hematol Oncol. 2024 Sep;42(5):e3303. doi: 10.1002/hon.3303. Hematol Oncol. 2024. PMID: 39105590
Monitoring Humoral Response Following BNT162b2 mRNA Vaccination against SARS-CoV-2 in Hematopoietic Stem-Cell Transplantation Patients: A Single-Center Prospective Study along with a Brief Review of Current Literature.
Asimakopoulos JV, Lalou E, Seferlis G, Malliarou M, Konstantinou E, Drandakis I, Vasilopoulos I, Georgopoulou AN, Kopsaftopoulou A, Machairas A, Piperidou A, Karapaschalidis A, Lefaki ME, Galopoulos D, Arapaki MP, Petsa P, Benekou E, Siakantaris MP, Papavassiliou AG, Tsaftaridis P, Panayiotidis P, Vassilakopoulos TP, Papapanagiotou A, Angelopoulou MK. Asimakopoulos JV, et al. Among authors: arapaki mp. Hematol Rep. 2024 Apr 16;16(2):220-233. doi: 10.3390/hematolrep16020022. Hematol Rep. 2024. PMID: 38651451 Free PMC article.
Prognostic Impact of Serum β2-Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 Patients.
Vassilakopoulos TP, Arapaki M, Diamantopoulos PT, Liaskas A, Panitsas F, Siakantaris MP, Dimou M, Kokoris SI, Sachanas S, Belia M, Chatzidimitriou C, Konstantinou EA, Asimakopoulos JV, Petevi K, Boutsikas G, Kanellopoulos A, Piperidou A, Lefaki ME, Georgopoulou A, Kopsaftopoulou A, Zerzi K, Drandakis I, Dimopoulou MN, Kyrtsonis MC, Tsaftaridis P, Plata E, Variamis E, Tsourouflis G, Kontopidou FN, Konstantopoulos K, Pangalis GA, Panayiotidis P, Angelopoulou MK. Vassilakopoulos TP, et al. Among authors: arapaki m. Cancers (Basel). 2024 Jan 5;16(2):238. doi: 10.3390/cancers16020238. Cancers (Basel). 2024. PMID: 38254729 Free PMC article.
Bone Marrow Iron Stores Are Not Associated with Increased Risk for Invasive Fungal Infections in Patients with Newly Diagnosed Acute Leukemia or Myelodysplastic Syndrome in Transformation: Is There a Relationship?
Apostolidi EA, Gamaletsou MN, Arapaki M, Asimakopoulos JV, Diamantopoulos P, Zafeiratou S, Kofteridis D, Pagoni M, Kotsopoulou M, Voulgarelis M, Sipsas NV. Apostolidi EA, et al. Among authors: arapaki m. J Fungi (Basel). 2023 Jul 14;9(7):748. doi: 10.3390/jof9070748. J Fungi (Basel). 2023. PMID: 37504736 Free PMC article.
Leukemic form of high-grade B-cell lymphoma (HGBL) in a very elderly patient with multiple comorbidities: effective treatment of a very rare subtype with a mini-R-da-EPOCH version.
Belia M, Drandakis I, Lakiotaki E, Arapaki M, Panitsas F, Triantafyllou EF, Plata E, Siakantaris MP, Angelopoulou MK, Korkolopoulou P, Vassilakopoulos TP. Belia M, et al. Among authors: arapaki m. Ann Hematol. 2023 Aug;102(8):2279-2282. doi: 10.1007/s00277-023-05214-5. Epub 2023 Apr 28. Ann Hematol. 2023. PMID: 37115296 No abstract available.
Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors.
Vassilakopoulos TP, Kravvariti E, Panitsas F, Angelopoulou MK, Liaskas A, Kontopidou FN, Yiakoumis X, Variami E, Dimopoulou MN, Siakantaris MP, Asimakopoulos JV, Arapaki M, Dimou M, Diamantopoulos P, Sachanas S, Chatzidimitriou C, Belia M, Konstantinou E, Boutsikas G, Petevi K, Kanellopoulos A, Kokoris S, Kyrtsonis MC, Viniou NA, Lakiotaki E, Tsourouflis G, Korkolopoulou P, Konstantopoulos K, Panayiotidis P, Pangalis GA. Vassilakopoulos TP, et al. Among authors: arapaki m. Blood Cancer J. 2022 Jul 5;12(7):102. doi: 10.1038/s41408-022-00674-w. Blood Cancer J. 2022. PMID: 35790712 Free PMC article. No abstract available.
Serum ferritin levels in previously untreated classical Hodgkin lymphoma: correlations and prognostic significance.
Karakatsanis S, Panitsas F, Arapaki M, Galopoulos D, Asimakopoulos JV, Liaskas A, Chatzidimitriou C, Belia M, Konstantinou E, Vassilopoulos I, Papadatos SS, Sachanas S, Efstathopoulou M, Yiakoumis X, Pardalis V, Iliakis T, Giannakopoulou N, Dimou M, Chatzidavid S, Boutsikas G, Petevi K, Kanellopoulos A, Gainaru G, Variamis E, Siakantaris MP, Kyrtsonis MC, Plata E, Tsaftaridis P, Dimopoulou MN, Viniou NA, Syrigos KN, Pangalis GA, Panayiotidis P, Konstantopoulos K, Angelopoulou MK, Vassilakopoulos TP. Karakatsanis S, et al. Among authors: arapaki m. Leuk Lymphoma. 2022 Apr;63(4):799-812. doi: 10.1080/10428194.2021.2010054. Epub 2022 Feb 19. Leuk Lymphoma. 2022. PMID: 35188040
Very Early Onset of Therapy-Related Acute Myeloid Leukemia with 11q23 Rearrangement Presenting with Unusual PET Findings after R-DA-EPOCH for Primary Mediastinal Large B-Cell Lymphoma.
Chatzidimitriou C, Rondogianni P, Arapaki M, Liaskas A, Plata E, Angelopoulou MK, Tsirigotis P, Vassilakopoulos TP. Chatzidimitriou C, et al. Among authors: arapaki m. Medicina (Kaunas). 2021 Dec 29;58(1):48. doi: 10.3390/medicina58010048. Medicina (Kaunas). 2021. PMID: 35056356 Free PMC article.
Real-life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B-cell lymphomas.
Dimou M, Papageorgiou SG, Stavroyianni N, Katodritou E, Tsirogianni M, Kalpadakis C, Banti A, Arapaki M, Iliakis T, Bouzani M, Verrou E, Spanoudakis E, Giannouli S, Marinakis T, Mandala E, Mparmparousi D, Sachanas S, Dalekou-Tsolakou M, Hatzimichael E, Vadikolia C, Violaki V, Poziopoulos C, Tsirkinidis P, Chatzileontiadou S, Vervessou E, Ximeri M, Sioni A, Konstantinidou P, Kyrtsonis MC, Siakantaris MP, Angelopoulou MK, Pappa V, Konstantopoulos K, Panayiotidis P, Vassilakopoulos TP. Dimou M, et al. Among authors: arapaki m. Hematol Oncol. 2021 Aug;39(3):336-348. doi: 10.1002/hon.2842. Epub 2021 Mar 2. Hematol Oncol. 2021. PMID: 33583077
17 results